Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexicon Pharmaceuticals (LXRX) FCF Margin (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed FCF Margin for 4 consecutive years, with 2497.54% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin fell 239025.0% to 2497.54% in Q4 2025 year-over-year; TTM through Dec 2025 was 229.57%, a 57955.0% increase, with the full-year FY2025 number at 150.78%, up 56846.0% from a year prior.
  • FCF Margin was 2497.54% for Q4 2025 at Lexicon Pharmaceuticals, down from 58.87% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 58.87% in Q2 2025 to a low of 3081.49% in Q3 2024.